Found 7 matching trials
A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
PHASE1The purpose of this clinical study is to evaluate the safety and immunogeni...
Location
Hubei Provincial Center for Disease Control and Prevention
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above
PHASE1The purposes of the study are to evaluate the safety and tolerability of di...
Status
Active Not Recruiting
Location
Yanjin District Center for Disease Control and Prevention
A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and Older
PHASE2This phase 2 study in China will evaluate the immunogenicity and safety of ...
Status
Active Not Recruiting
Location
Hengnan County Center for Disease Control and Prevention
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
PHASE1This phase 1 study in China will evaluate the safety and immunogenicity of ...
Location
Guangdong Provincial Center for Disease Control and Prevention
A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
PHASE1This clinical trial is to study the safety and tolerability of a recombinan...
Location
Frontage Clinical Services, Inc.
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
PHASE4Introduction: Patients with autoimmune rheumatic diseases (ARDs), rheumatoi...
Status
Active Not Recruiting
Location
Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo
Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older
PHASE1The objective of this study was to evaluate the safety, immunogenicity and ...
Status
Active Not Recruiting
Location
Xiangcheng County Center for Disease Control and Prevention